Sensorion Secures €60M to Advance Gene Therapies for Hearing Loss
MONTPELLIER, France | January 28, 2026 — Sensorion, a clinical-stage biotechnology company focused on hearing loss disorders, announced a...
GxP compliance
Advertisement
Waters Sets Q4 2025 Earnings Call, Signals GxP Tech Focus
Milford, Massachusetts, January 20, 2026 — Waters Corporation, a global leader in analytical instruments, separations technologies, and laboratory software,...
BrightInsight Raises $13M to Scale AI Medication Adherence Tech
SAN JOSE, Calif., January 20, 2026 — BrightInsight announced a $13 million strategic investment to accelerate development of its...
Nona Biosciences Scales Discovery-to-Clinical Biologics Platform
Cambridge, Massachusetts — January 8, 2026 — Nona Biosciences announced a strategic expansion of its integrated discovery and development...
L7 and Turnberry Unite to Scale AI-Driven Life Sciences Data
Austin, Texas, and Minneapolis, Minnesota — January 8, 2026 — L7 Informatics and Turnberry Solutions announced a strategic teaming...
Advertisements
Diagonal Therapeutics Secures $125M Series B to Advance Pipeline
CAMBRIDGE, Mass. | January 8, 2026 — Diagonal Therapeutics, a biotechnology company developing disease-modifying clustering antibody therapies, announced the...
AI Grant Aims to Boost Biologics Developability at Just – Evotec
SAN DIEGO | January 8, 2026 — Just – Evotec Biologics, a collaboration between Evotec SE and Just –...
HEMOSTEMIX EXPANDS CLINICAL OPERATIONS WITH NEW PATIENT-CARE DIRECTOR
CALGARY, Alberta — December 4, 2025 — Hemostemix Inc., a leader in autologous stem-cell therapeutics, has appointed Shaune Harding,...
Phio Pharmaceuticals Strengthens Governance with New Lead Director
King of Prussia, Pennsylvania – October 31, 2025 — Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage biopharmaceutical company developing...
Advertisement
